Perhaps this is because the IRF2-deficient tumor cells are able to evade NK cells because they still expresses some MHC I molecules and/or have decreased caspase 7, however further studies are needed to determine whether and to what extent NK cells can recognize and control IRF2-deficient cancers. This evidence concerns the gene CASP7 and cancer.